Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Gary Feiss"'
Autor:
Hendrika W. Grievink, Silvana M. G. Jirka, Tess D. Woutman, Mascha Schoonakker, Robert Rissmann, Karen E. Malone, Gary Feiss, Matthijs Moerland
Publikováno v:
Clinical and Translational Science, Vol 13, Iss 5, Pp 891-895 (2020)
LL‐37 is a cationic antimicrobial peptide and the sole human member of cathelicidins. Besides its bactericidal properties, LL‐37 is known to have direct immunomodulatory effects, among which enhancement of antiviral responses via endosomal toll
Externí odkaz:
https://doaj.org/article/f3c81ec86b354db9bc8ac7829c51fcef
Autor:
Tessa Niemeyer‐van der Kolk, Salma Assil, Thomas P. Buters, Melanie Rijsbergen, Erica S. Klaassen, Gary Feiss, Edwin Florencia, Errol P. Prens, Jacobus Burggraaf, Martijn B.A. vanDoorn, Robert Rissmann, Matthijs Moerland
Publikováno v:
Clinical and Translational Science, Vol 13, Iss 3, Pp 573-579 (2020)
Omiganan (OMN; a synthetic cationic peptide) and imiquimod (IMQ; a TLR7 agonist) have synergistic effects on interferon responses in vitro. The objective of this study was to translate this to a human model for proof‐of‐concept, and to explore th
Externí odkaz:
https://doaj.org/article/42391760444a4082ab3df6cc9a119ef1
Autor:
Wouter ten Voorde, Mahdi Saghari, Jiry Boltjes, Marieke L. de Kam, Ahnjili Zhuparris, Gary Feiss, Thomas P. Buters, Errol P. Prens, Jeffrey Damman, Tessa Niemeyer‐van der Kolk, Matthijs Moerland, Jacobus Burggraaf, Martijn B. A. van Doorn, Robert Rissmann
Publikováno v:
Experimental Dermatology. Wiley-Blackwell Publishing Ltd
Experimental Dermatology
Experimental Dermatology
Development of pharmacological interventions for wound treatment is challenging due to both poorly understood wound healing mechanisms and heterogeneous patient populations. A standardized and well-characterized wound healing model in healthy volunte
Autor:
Bertine W. Huisman, Lauren E. H. Nené, Feeke L. L. Linders, Tom K. Gambrah, Tessa Niemeyer van der Kolk, Marieke L. de Kam, Jan Nico Bouwes Bavinck, Jacobus Burggraaf, Gary Feiss, Robert Rissmann
Publikováno v:
Journal of the European Academy of Dermatology and Venereology
Autor:
Daniel Kozo, Holly Soares, Adam J. Simon, Gary Feiss, Jodi Blake Courtney, Kim Williams, Caitlin N. Baldasano, George Green, Salvatore J. Salamone, Irina Baburina
Publikováno v:
Alzheimer's & Dementia. 10
of the optical densities in ten repetitions of the standard curves was 5% for all standards. In the clinical part, at the cut off value 691 pg/mL, Ab 1-42 showed the sensitivity and the specificity of 69.3 %, and 88.9%, respectively, whereas at the c
Autor:
John A. Winder, Brandon Simpson, Gary Feiss, William S. Silvers, Julius H. van Bavel, Joseph A. Smith, Charles H. Banov, Andrew W. Green, John A. Furst
Publikováno v:
Clinical Therapeutics. 18:265-272
Triamcinolone acetonide (TAA) aerosol nasal inhaler has been shown to effectively relieve the symptoms of seasonal allergic rhinitis in adults and adolescents. We conducted a study to evaluate the efficacy and safety of once-daily administration of T
Autor:
D. Loren Southern, John A. Furst, Brandon Simpson, Joseph A. Smith, William W. Storms, Gary Feiss
Publikováno v:
Pediatric Asthma, Allergy & Immunology. 10:59-64
Triamcinolone acetonide (TAA) aerosol nasal inhaler is an effective and well-tolerated treatment for symptoms of perennial allergic rhinitis (PAR). This multicenter, randomized, double-blind, placebo-controlled study evaluated the efficacy and safety
Autor:
William M. Lee, Timothy J Friel, Laura Kriebel, Geraldine B. Guillon, Mark Fischl, Alexander Monto, Keith W. Kardos, Lisa A. Kurtz, Eugene R. Schiff, Scott E. Eder, Jay Lynn Unangst, Cheryl A. Berne, Alpha T. Banks, Karam Mounzer, Harvey A. Tatum, Michael P. DeMicco, Stephen R. Lee, Gary Feiss, Michele Roehler, Graham Yearwood
Publikováno v:
Journal of virological methods. 172(1-2)
The availability of a highly accurate, rapid, point-of-care test for hepatitis C virus (HCV) may be useful in addressing the problem of under-diagnosis of HCV, by increasing opportunities for testing outside of traditional clinical settings. A new HC
Publikováno v:
Chest. 112(3)
This multicenter, double-blind, placebo-controlled study evaluated the dose response to 6 weeks of triamcinolone acetonide inhalation aerosol (TAA, 100 microg per puff) in patients with moderately severe asthma.A total of 285 patients were randomly a
Autor:
Wilfred N. Beaucher, John A. Furst, Joseph A. Smith, James P. Rosen, Brandon Simpson, Jerald W. Koepke, James H. Ransom, Gary Feiss, Roger H. Kobayashi
Publikováno v:
Allergy and asthma proceedings. 18(1)
This 12-month, multicenter, open-label study to assess the long-term safety and efficacy of triamcinolone acetonide (TAA) aqueous nasal spray for perennial allergic rhinitis (PAR) symptom relief was a continuation of a 4-week, double-blind study. Pat